Literature DB >> 6852999

The pharmacokinetics and availability of niflumic acid in humans.

G Houin, D Tremblay, F Bree, A Dufour, P Ledudal, J P Tillement.   

Abstract

The pharmacokinetic parameters and relative availability of niflumic acid in two different pharmaceutical preparations were studied in 12 subjects after a single oral administration. Total plasma clearance averaged 45 ml/min, and the half-life of elimination approximately 2 h, giving a distribution volume of 0.12 l/kg on the average. The values of these pharmacokinetic parameters were in agreement with the general characteristics of this type of substance, a weak acid strongly bound to plasma proteins. Comparison of the systemic availability of the two oral forms showed no difference; they were probably close to 100%.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6852999

Source DB:  PubMed          Journal:  Int J Clin Pharmacol Ther Toxicol        ISSN: 0174-4879


  2 in total

1.  Identification of human UDP-glucuronosyltransferase responsible for the glucuronidation of niflumic acid in human liver.

Authors:  Yuji Mano; Takashi Usui; Hidetaka Kamimura
Journal:  Pharm Res       Date:  2006-06-21       Impact factor: 4.200

2.  Characterization of the interaction between fenamates and hippocampal neuron GABA(A) receptors.

Authors:  Leanne Coyne; Jiping Su; Debra Patten; Robert F Halliwell
Journal:  Neurochem Int       Date:  2007-05-03       Impact factor: 3.921

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.